| 000 | 01695 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518020356.0 | ||
| 264 | 0 | _c20200921 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1365-2133 | ||
| 024 | 7 |
_a10.1111/bjd.17641 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVossen, A R J V | |
| 245 | 0 | 0 |
_aThe anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study. _h[electronic resource] |
| 260 |
_bThe British journal of dermatology _c08 2019 |
||
| 300 |
_a314-323 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntigens, CD20 _ximmunology |
| 650 | 0 | 4 |
_aAntimicrobial Cationic Peptides _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aBiological Products _xpharmacology |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealthy Volunteers |
| 650 | 0 | 4 |
_aHidradenitis Suppurativa _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-12 Subunit p40 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aInterleukin-17 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOrgan Culture Techniques |
| 650 | 0 | 4 |
_aPrednisolone _xpharmacology |
| 650 | 0 | 4 |
_aSkin _xdrug effects |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aArdon, C B | |
| 700 | 1 | _avan der Zee, H H | |
| 700 | 1 | _aLubberts, E | |
| 700 | 1 | _aPrens, E P | |
| 773 | 0 |
_tThe British journal of dermatology _gvol. 181 _gno. 2 _gp. 314-323 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bjd.17641 _zAvailable from publisher's website |
| 999 |
_c29267951 _d29267951 |
||